INT314749

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.17
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 2.83
Pain Relevance 0.13

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

enzyme regulator activity (Psmd1) cellular_component (Psmd1)
Psmd1 (Mus musculus)
Pain Link Frequency Relevance Heat
abdominal pain 2 72.88 Quite High
dexamethasone 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Stomach Cancer 34 99.80 Very High Very High Very High
Cancer 34 91.04 High High
Metastasis 12 84.60 Quite High
Abdominal Pain 2 72.88 Quite High
Fatigue 2 71.68 Quite High
Diarrhoea 2 70.92 Quite High
Anorexia 10 70.08 Quite High
Vomiting 4 68.76 Quite High
Hypesthesia 2 66.64 Quite High
Disorders Of The Lacrimal System 2 65.48 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In more than 4,000 patients administered S-1 for gastric cancer, 25% have experienced grade 3 or higher toxicities, and their MST was 8.3 months.7 We herein observed an occurrence of grade 3 or higher toxicities in 9.4% of patients, a response rate of 38.4%, and a median survival rate of 343 days in the patients who received S-1 monotherapy for advanced or recurrent gastric cancer.8
Positive_regulation (received) of Gene_expression (monotherapy) of S-1 associated with stomach cancer
1) Confidence 0.17 Published 2010 Journal Clinical Medicine Insights. Oncology Section Body Doc Link PMC2883242 Disease Relevance 1.21 Pain Relevance 0.06
In more than 4,000 patients administered S-1 for gastric cancer, 25% have experienced grade 3 or higher toxicities, and their MST was 8.3 months.7 We herein observed an occurrence of grade 3 or higher toxicities in 9.4% of patients, a response rate of 38.4%, and a median survival rate of 343 days in the patients who received S-1 monotherapy for advanced or recurrent gastric cancer.8
Positive_regulation (administered) of Gene_expression (administered) of S-1 associated with stomach cancer
2) Confidence 0.17 Published 2010 Journal Clinical Medicine Insights. Oncology Section Body Doc Link PMC2883242 Disease Relevance 1.62 Pain Relevance 0.07

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox